IMO nan should use their SP for some acquisitions either script take over or CR. They need to expand their distribution network in asian and europe. Rather than replication takeover a synergistic medical distribution company. You get efficiencies of scale and an instant network and potential goodwill with the right purchase. Alternatively takeover of a related disinfection company to increase portfolio and reduce risk.
Is NAN the BEST Growth Story on the ASX MF, page-3
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.10 |
Change
0.180(6.16%) |
Mkt cap ! $939.2M | |||
| Open | High | Low | Value | Volume |
| $2.95 | $3.12 | $2.95 | $4.521M | 1.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3776 | $3.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.10 | 10028 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.10 |
Change
0.180 ( 6.50 %) |
||||
| Open | High | Low | Volume | ||
| $2.96 | $3.12 | $2.95 | 307297 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| NAN (ASX) Chart |